Cardiology Today Current Issue

The following articles appeared in the print edition of Cardiology Today.

Table of Contents

• Unclear CV risk burden of polycystic ovary syndrome presents challenges for cardiologists
• A practical approach to tobacco dependence for clinicians, smokers Elizabeth Ratchford, MD; Roger S. Blumenthal, MD; Pranoti G. Hiremath, MD
• Deep dive: Cancer-related therapies and advanced HF Barry Trachtenberg, MD, FACC; Javid J. Moslehi, MD
• Cardiac output monitoring device receives FDA clearance
• FDA panel: Febuxostat benefits outweigh CV risks, but reduce use
• FDA panel supports premarket approval of implantable pulse generator for HF
• Next-generation balloon-expandable TAVR valve receives FDA approval
• Comprehensive cardiac rehab confers improved functional capacity, BP reduction
• CONSERVE: Selective referral using CTA efficient for suspected CAD
• Evolocumab response rate high in FOURIER population
• Less than 6 hours of sleep per night increases atherosclerosis risk
• Hypertension incidence higher in socioeconomically deprived neighborhoods
• Increased peak oxygen uptake may benefit in lowering CHD risk
• Liraglutide CV benefits consistent across kidney function, MI, stroke status
• Long-term sitting affects vascular health
• Mediterranean diet decreases risk for CVD events in women
• Monitoring through ICDs, pacemakers decreases anticoagulation administration
• Mortality rates lower in Holocaust survivors regardless of comorbidities
• Myocardial strain increases with longer races for amateur runners
• Possible mortality risk from paclitaxel-coated devices spurs debate, pauses trials
• PRIME: Sacubitril/valsartan reduces mitral regurgitation
• Thyroid dysfunction confers poor prognosis in HF
• CDC: Heart disease, cancer leading causes of death in 2017
• AF admissions increase at start of daylight saving time
• CAC scoring, biomarkers may help CVD risk prediction
• Cell therapy fails to improve cardiac recovery in advanced HF
• Consideration of CV health important during breast cancer treatment
• CPR education laws increase survival rates in out-of-hospital cardiac arrest
• Daily weighing may help with weight loss
• EMPA-HEART: Empagliflozin reduces LV mass in type 2 diabetes
• New-onset AF similar after TAVR, surgical AVR
• Proper nutrition can change course of CHD, other diseases
• Role of antithrombotic therapy evolving
• ASCERTAIN
• CANTIC
• COMPASS-CABG
• CONSERVE
• LVAD MPC-II
• PRIME
• REAC-TAVI
• RESPOND